Agency Information Collection Activities: Proposed Collection; Comments Requested, 48681-48682 [E7-16790]

Download as PDF Federal Register / Vol. 72, No. 164 / Friday, August 24, 2007 / Notices yshivers on PROD1PC66 with NOTICES respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection (1) Type of Information Collection: Extension of an existing collection. (2) Title of the Form/Collection: Application for Individual Manufacturing Quota for a Basic Class of Controlled Substance and for Ephedrine, Pseudoephedrine, and Phenylpropanolamine. (3) Agency form number, if any and the applicable component of the Department sponsoring the collection: Form number: DEA Form 189. Component: Office of Diversion Control, Drug Enforcement Administration, U.S. Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other for-profit. Other: None. Abstract: 21 U.S.C. 826 and 21 CFR 1303.22 and 1315.22 require that any person who is registered to manufacture any basic class of controlled substances listed in Schedule I or II and who desires to manufacture a quantity of such class, or who desires to manufacture using the List I chemicals ephedrine, pseudoephedrine, or phenylpropanolamine, must apply on DEA Form 189 for a manufacturing quota for such quantity of such class or List I chemical. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: DEA estimates that each form takes 0.5 hours (30 minutes) to complete. In total, 37 firms submit 298 responses, with each response taking 0.5 hours (30 minutes) to complete. This results in a total public burden of 149 hours annually. (6) An estimate of the total public burden (in hours) associated with the collection: In total, 37 firms submit 298 responses, with each response taking 0.5 hours (30 minutes) to complete. This results in a total public burden of 149 hours annually. If additional information is required contact: Lynn Bryant, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street, NW., Washington, DC 20530. VerDate Aug<31>2005 14:35 Aug 23, 2007 Jkt 211001 Dated: August 20, 2007. Lynn Bryant, Department Clearance Officer, PRA, Department of Justice. [FR Doc. E7–16718 Filed 8–23–07; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117–0008] Agency Information Collection Activities: Proposed Collection; Comments Requested 30-day notice of information collection under review: Application for procurement quota for controlled substances and ephedrine, pseudoephedrine, and phenylpropanolamine. ACTION: The Department of Justice (DOJ), Drug Enforcement Administration (DEA) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register Volume 72, Number 117, page 33775 on June 19, 2007, allowing for a 60-day comment period. The purpose of this notice is to allow for an additional 30 days for public comment until September 24, 2007. This process is conducted in accordance with 5 CFR 1320.10. Written comments and/or suggestions regarding the items contained in this notice, especially the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503. Additionally, comments may be submitted to OMB via facsimile to (202) 395–5806. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 48681 —Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection (1) Type of Information Collection: Revision of an existing collection. (2) Title of the Form/Collection: Application for Procurement Quota for Controlled Substances and Ephedrine, Pseudoephedrine, and Phenylpropanolamine. (3) Agency form number, if any and the applicable component of the Department sponsoring the collection: Form number: DEA Form 250. Component: Office of Diversion Control, Drug Enforcement Administration, U.S. Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other for-profit. Other: None. Abstract: 21 U.S.C. 826 and 21 CFR 1303.12 and 1315.32 require that U.S. companies who desire to use any basic class of controlled substances listed in Schedule I or II or the List I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for purposes of manufacturing during the next calendar year shall apply on DEA Form 250 for procurement quota for such class or List I chemical. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: DEA estimates that each form takes 1 hour to complete. DEA estimates that 240 individual respondents will respond to this form. (6) An estimate of the total public burden (in hours) associated with the collection: 240 individual respondents will spend one hour annually completing this form for the List I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. This results in an annual public burden of 240 hours. This form is already used to collect information regarding controlled E:\FR\FM\24AUN1.SGM 24AUN1 48682 Federal Register / Vol. 72, No. 164 / Friday, August 24, 2007 / Notices substances quotas. For that aspect of this collection, 255 respondents submit 1,106 responses annually, for a public burden of 1,106 hours annually. DEA notes that the controlled substances aspect of this collection is not being adjusted or revised. Therefore, the total public burden for this collection is 1,346 hours annually. If additional information is required contact: Lynn Bryant, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street, N.W., Washington, DC 20530. Dated: August 20, 2007. Lynn Bryant, Department Clearance Officer, PRA, Department of Justice. [FR Doc. E7–16790 Filed 8–23–07; 8:45 am] BILLING CODE 4410–09–P Overview of This Information Collection DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117–0043] Agency Information Collection Activities: Proposed Collection; Comments Requested 60-day notice of information collection under review—drug questionnaire DEA Form 341. yshivers on PROD1PC66 with NOTICES ACTION: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted until October 23, 2007. This process is conducted in accordance with 5 CFR 1320.10. If you have comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Catherine J. Kasch, Assistant Administrator, Human Resources Division, Drug Enforcement Administration, Washington, DC 20537. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: VerDate Aug<31>2005 14:35 Aug 23, 2007 —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Jkt 211001 (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: Drug Questionnaire (DEA Form 341). (3) Agency form number, if any, and the applicable component of the Department sponsoring the collection: Form number: DEA Form 341. Component: Human Resources Division, Drug Enforcement Administration, U.S. Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Individuals. Other: None. Abstract: DEA Policy states that a past history of illegal drug use may be a disqualification for employment with DEA. This form asks job applicants specific questions about their personal history, if any, of illegal drug use. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: It is estimated that 31,800 respondents will respond annually, taking 5 minutes to complete each form. (6) An estimate of the total public burden (in hours) associated with the collection: 2,650 annual burden hours. If additional information is required contact: Lynn Bryant, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street, NW., Washington, DC 20530. PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 Dated: August 20, 2007. Lynn Bryant, Department Clearance Officer, PRA, Department of Justice. [FR Doc. E7–16791 Filed 8–23–07; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117–0047] Agency Information Collection Activities: Proposed Collection; Comments Requested 30-day notice of information collection under review: Application for import quota for ephedrine, pseudoephedrine, and phenylpropanolamine DEA Form 488. ACTION: The Department of Justice (DOJ), Drug Enforcement Administration (DEA) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register Volume 72, Number 117, page 33775 on June 19, 2007, allowing for a 60 day comment period. The purpose of this notice is to allow for an additional 30 days for public comment until September 24, 2007. This process is conducted in accordance with 5 CFR 1320.10. Written comments and/or suggestions regarding the items contained in this notice, especially the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503. Additionally, comments may be submitted to OMB via facsimile to (202) 395–5806. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agencies estimate of the burden of the E:\FR\FM\24AUN1.SGM 24AUN1

Agencies

[Federal Register Volume 72, Number 164 (Friday, August 24, 2007)]
[Notices]
[Pages 48681-48682]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-16790]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[OMB Number 1117-0008]


Agency Information Collection Activities: Proposed Collection; 
Comments Requested

ACTION: 30-day notice of information collection under review: 
Application for procurement quota for controlled substances and 
ephedrine, pseudoephedrine, and phenylpropanolamine.

-----------------------------------------------------------------------

    The Department of Justice (DOJ), Drug Enforcement Administration 
(DEA) will be submitting the following information collection request 
to the Office of Management and Budget (OMB) for review and approval in 
accordance with the Paperwork Reduction Act of 1995. The proposed 
information collection is published to obtain comments from the public 
and affected agencies. This proposed information collection was 
previously published in the Federal Register Volume 72, Number 117, 
page 33775 on June 19, 2007, allowing for a 60-day comment period.
    The purpose of this notice is to allow for an additional 30 days 
for public comment until September 24, 2007. This process is conducted 
in accordance with 5 CFR 1320.10.
    Written comments and/or suggestions regarding the items contained 
in this notice, especially the estimated public burden and associated 
response time, should be directed to the Office of Management and 
Budget, Office of Information and Regulatory Affairs, Attention 
Department of Justice Desk Officer, Washington, DC 20503. Additionally, 
comments may be submitted to OMB via facsimile to (202) 395-5806.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address one or more of the following 
four points:
--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agencies estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be 
collected; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

Overview of This Information Collection

    (1) Type of Information Collection: Revision of an existing 
collection.
    (2) Title of the Form/Collection: Application for Procurement Quota 
for Controlled Substances and Ephedrine, Pseudoephedrine, and 
Phenylpropanolamine.
    (3) Agency form number, if any and the applicable component of the 
Department sponsoring the collection:
    Form number: DEA Form 250.
    Component: Office of Diversion Control, Drug Enforcement 
Administration, U.S. Department of Justice.
    (4) Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Primary: Business or other for-profit.
    Other: None.
    Abstract: 21 U.S.C. 826 and 21 CFR 1303.12 and 1315.32 require that 
U.S. companies who desire to use any basic class of controlled 
substances listed in Schedule I or II or the List I chemicals 
ephedrine, pseudoephedrine, and phenylpropanolamine for purposes of 
manufacturing during the next calendar year shall apply on DEA Form 250 
for procurement quota for such class or List I chemical.
    (5) An estimate of the total number of respondents and the amount 
of time estimated for an average respondent to respond: DEA estimates 
that each form takes 1 hour to complete. DEA estimates that 240 
individual respondents will respond to this form.
    (6) An estimate of the total public burden (in hours) associated 
with the collection: 240 individual respondents will spend one hour 
annually completing this form for the List I chemicals ephedrine, 
pseudoephedrine, and phenylpropanolamine. This results in an annual 
public burden of 240 hours.
    This form is already used to collect information regarding 
controlled

[[Page 48682]]

substances quotas. For that aspect of this collection, 255 respondents 
submit 1,106 responses annually, for a public burden of 1,106 hours 
annually. DEA notes that the controlled substances aspect of this 
collection is not being adjusted or revised. Therefore, the total 
public burden for this collection is 1,346 hours annually.
    If additional information is required contact: Lynn Bryant, 
Department Clearance Officer, United States Department of Justice, 
Justice Management Division, Policy and Planning Staff, Patrick Henry 
Building, Suite 1600, 601 D Street, N.W., Washington, DC 20530.

    Dated: August 20, 2007.
Lynn Bryant,
Department Clearance Officer, PRA, Department of Justice.
 [FR Doc. E7-16790 Filed 8-23-07; 8:45 am]
BILLING CODE 4410-09-P